Autologous adipose-derived stem cells for the treatment of Crohn’s fistula-in-ano: an open-label, controlled trial

Autologous adipose-derived stem cells for the treatment of Crohn’s fistula-in-ano: an open-label, controlled trial

Abstract Background Crohn’s fistula-in-ano is a refractory disease in colorectal and anal surgery. Although autologous adipose-derived stem cell (ADSC) has been used in the treatment of Crohn’s fistula-in-ano because of its convenience, non-incision of normal tissue, good tolerance, repeatability, q...

Full description

Bibliographic Details
Main Authors: Chungen Zhou, Meng Li, Yang Zhang, Min Ni, Yehuang Wang, Dachao Xu, Yang Shi, Bo Zhang, Yanni Chen, Yan Huang, Sumin Zhang, Hongzhen Shi, Bin Jiang
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Stem Cell Research & Therapy
Subjects:
Autologous adipose-derived stem cells
Stem cell transplantation
Crohn’s fistula-in-ano
Efficacy
Safety
Online Access:http://link.springer.com/article/10.1186/s13287-020-01636-4

Internet

http://link.springer.com/article/10.1186/s13287-020-01636-4

Similar Items